How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice.

Volume: 32, Issue: 8, Pages: 531 - 538
Published: Dec 1, 2021
Abstract
Among children, neonates have the highest incidence of thrombosis due to risk factors such as catheter instrumentation, an evolving coagulation system and congenital heart disease. Low-molecular-weight heparins (LMWHs) are the most commonly used anticoagulants in neonates. Published guidelines delineate dosing and monitoring protocols for LMWH therapy in newborns. However, challenging clinical situations frequently present that warrant...
Paper Details
Title
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice.
Published Date
Dec 1, 2021
Volume
32
Issue
8
Pages
531 - 538
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.